NCT03772223 - A Study to Compare the Pharmacokinetics of Budesonide and Albuterol Delivered by PT027 Compared With PT007 and PT008 Administered Separately. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 21, 2019

Primary Completion Date

May 10, 2019

Study Completion Date

May 10, 2019

Conditions

Healthy Volunteers

Interventions

DRUG

Treatment A (Budesonide/Albuterol Sulfate metered dose inhaler)

Randomized participants will receive a single-dose (2 inhalations, 2 x 80/90 µg).

DRUG

Treatment B (Budesonide metered dose inhaler)

Randomized participants will receive a single-dose (2 inhalations, 2 x 80 µg).

DRUG

Treatment C (Albuterol Sulfate metered dose inhaler)

Randomized participants will receive a single-dose (2 inhalations, 2 x 90 µg).

Trial Locations (1)

Research Site, London